* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download HIV lecture Sept 2011 101
Survey
Document related concepts
Transcript
Pacific AIDS Education &Training Center San Joaquin Valley Local Performance Site Andrés E. Alba Program Manager UCSF Fresno Family and Community Medicine Norma Sanchez – Fresno County Department of Community Health, Communicable Disease Division What are we (who am I)? • The AIDS Education and Training Centers (AETC) Program of the Ryan White CARE Act currently supports a network of 11 regional centers and more than 130 local performance sites (LPS). The AETCs serve all 50 States, the District of Columbia, the Virgin Islands, Puerto Rico, and the six U.S.-affiliated Pacific Jurisdictions • The AETC Program is administered by the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau What do we do? • The AETC conducts targeted, multi-disciplinary education and training programs for healthcare providers treating persons with HIV/AIDS and other infectious diseases What is our Mission? • To improve the quality of life of patients living with HIV/AIDS through the provision of high quality professional education and training Who do we train? Providers who serve minority populations, the homeless, rural communities, or incarcerated persons; community and migrant health centers, and Ryan White CARE Act-funded sites Physicians Advanced practice nurses Nurses Physician assistants Pharmacists Oral health professionals Other healthcare professionals, including medical case managers Educators/Teachers What type of trainings do we offer? • Lectures and didactic seminars • Workshops, seminars and hands-on clinical experience • Local clinical consultation on all aspects of managing patient care • Intensive clinical rotations, preceptorships and miniresidencies • Technical assistance in quality HIV care • Training activities are based upon assessed local needs * Since 1991, the AETC’s have sponsored more than 700,000 trainings Nationally. San Joaquin Valley (SJV) Local Performance Site • Service 6 Counties throughout Central Valley – Merced – Madera – Fresno (UCSF Fresno*) – Kings – Tulare – Kern Local Resources • • • • • • • SJV AETC Medical Director – Ivan Gomez, MD Specialty Clinic Medical Director – Simon Paul, MD Faculty and Chief of F.M. – Roger Mortimer, MD I.D. Fellowship Director – Naiel Nassar, MD HIV Fellow – Hugh Yang, DO SJV AETC Program Manager – Andrés E. Alba Communicable Disease Specialist with Fresno County – Norma Sanchez 1992 Facts • The people who are starting college this fall were born in 1992. • They are too young to remember the space shuttle blowing up. • The CD was introduced two years before they were born. • They have always had an answering machine. • They have always had cable. 1992 Facts • Jay Leno has always been on the Tonight Show. • Popcorn has always been microwaved. • They never took a swim and thought about Jaws. • They don't know who Mork was or where he was from. 1992 Facts • They never heard: 'Where's the Beef?', 'I'd walk a mile for a Camel ' or 'de plane Boss, de plane'. • McDonald's never came in Styrofoam containers. • They don't have a clue how to use a typewriter. • Their lifetime has always included AIDS. HIV 101 How many of you in the last 30 days have done illegal activities? 1. Talking on the phone while driving. 2. Texting on the phone while driving. 3. Both 1 and 2 4. I plead the 5th! 33% 31% 25% 11% 1 2 3 4 Key Terms • • • • • • • HIV—Human Immunodeficiency Virus AIDS—Acquired Immunodeficiency Syndrome Transmission HIV Antibody Testing CD4 Cell Count and Percentage (T-Lymphocytes) Viral Load/Viral Burden Resistance Testing – Genotype – Phenotype – Trophile Assay Key Terms • Antiretroviral Therapy – HAART—Highly Active Antiretroviral Therapy – Classes of Medications – Medication Regimen – Adherence – Viral Resistance • Treatment Guideline Changes • HIV Lifecycle What is HIV? 1. 2. 3. 4. A retrovirus A bacteria A virus A mutated cell 67% 33% 0% 1 2 0% 3 4 What does HIV do? 1. Infects human cells displaying CD4 (HelperInducer T-lymphocytes, and a few more) 2. Integrates itself into the host chromosome 3. Directs the cell to make more. 4. All of the Above 92% 8% 0% 1 2 0% 3 4 HIV comes from… 71% 23% 1. 2. 3. 4. 3% Vaccine trials in Africa Chimpanzees in Africa A CIA plot Mutation of a human herpes virus 1 3% 2 3 4 Origins • The first leap happened between 1919 and 1945. • Butchering of chimpanzees for ‘bush meat’ is the presumed mechanism. Worobey, Nature 2008; 455:661-664 To Demonstrate cross-over from one species (Chimpanzees—SIV) to another (Humans—HIV): what to look for? • • • • • similar genome organization phylogenetic relatedness prevalence in the natural host geographic coincidence plausible routes of transmission Origins • HIV-1 is a descendant of SIV from the chimpanzee (Pan troglodytes). • The jump to humans has happened at least 3 different times. • Most human disease comes from group M, clade B. Wain et al. Mol Biol Evol, (2007) 24 (8): 1853 HIV: Antiretroviral Therapy Nucleoside Analogue RTI Entry Inhibitors RT HIV RNA HIV DNA HIV Non-Nucleoside RTI Host Cell Nucleus Protease Inhibitors DHS/P Entry Inhibitors Reverse Transcriptase Inhibitors Intergrase Inhibitor Raltegravir (RAL) Isentress (2007) Protease Inhibitors Treatment for HIV-HAART Antiretroviral medications—6 classes, 32 different medications: Nucleoside Reverse Transcriptase Inhibitors AZT, 3tc, d4t, abacavir, DDI, tenofovir, emtricitabine Non-Nucleoside Reverse Transcriptase Inhibitors Nevirapine, efavirenz Protease Inhibitors Kaletra, Reyataz, Invirase, Crixivan, Norvir, Agenerase, Viracept Fusion Inhibitors Fuzeon Entry Inhibitors Selzentry Integrase Inhibitors Isentress In a healthy person the number of CD4 cells is… 64% 1. 100 - 300 2. 300 - 700 3. 700 – 1500 24% 12% 1 2 3 If you are infected with HIV other people can tell? 1. True 2. False 95% 5% 1 2 Viral Load Test • Also called an RNA PCR. This test measures the number of copies of the HIV virus present in the blood. – Ranges from undetectable (<50 to millions). People infected with HIV get sick and die quickly 1. True 2. False 97% 3% 1 2 Which person did NOT die from AIDS? 1. 2. 3. 4. 5. 6. Rock Hudson Tupac Shakur Anthony Perkins Freddie Mercury Eazy E. Robert Reed 89% 0% 1 2 3% 3% 3% 3% 3 4 5 6 Epidemiology What is Incidence? Incidence is a measure of the risk of developing some new condition within a specified period of time. Simply it is the number (#) of new cases during some time (t) period, it is better expressed as a proportion or a rate with a denominator What is Prevalence? The total number of cases of the disease in the population at a given time, or the total number of cases in the population, divided by the number of individuals in the population. a as the number of individuals in a given population with the disease at a given time, and b as the number of individuals in the same population at risk of developing the disease at a given time, not including those already with the disease Epidemiology • • • • • Incidence remaining the same. Prevalence increasing (why?) 40-60,000 new HIV cases per year in the USA. 900,000 cases of HIV/AIDS in USA 1/3 don’t know status. Epidemiology • 2008—CDC adjusted its estimates of new HIV infections – New technologies – Previous estimations placed new infection rate at 40,000 persons per year – Dramatic decrease in numbers from over 130,000 in 1980s to ~50,000 in the 1990s – In 2006, CDC estimates 56,000 people were infected with HIV CDC. 2009 HIV No Name Reporting • 2004 – only reported with first letter of last name, date of birth, and last 4 digits of Social Security • 2007 – CDC recommends names reporting • CA – one of the last states to report by name • Now HIV and AIDS reported by names U.S. Demographics and Spread of AIDS National Statistics CDC, 1997 National Statistics CDC, 1997 National Statistics CDC, 1997 National Statistics CDC, 1997 National Statistics CDC, 1997 Fresno Stats Transmission HIV can be transmitted via 1. 2. 3. 4. 5. 6. 7. Sex Injection Drugs Sharing toothbrushes Drinking glasses Childbirth 1, 2, & 5. 1, 2, & 3. 87% 8% 0% 1 3% 2 0% 3 3% 4 0% 5 6 7 HIV Transmission Vertical Transmission • Also called Mother to Child Transmission (MTCT). • Transmission of the virus to the child either: – During pregnancy – 25%. – Intrapartum – 75%. – Post Partum – breast feeding increases the risk of transmission by 14% (26% risk if newly infected mother). Exposed Infant • Baby born to an HIV positive mother, does not necessarily mean the baby has the infection. A discordant couple is 1. Couples who fight a lot 2. Couples who can’t agree about birth control methods 3. Couples where one partner is HIV + and one partner is HIV – 4. Couples who play musical instruments badly 79% 12% 6% 1 3% 2 3 4 HIV Infection Sequence of events: • HIV is transmitted with extension to regional lymph tissue (within the first few days of exposure). HIV Infection Massive viremia – billions of virions produced every day. • Transmission risk is high – asymptomatic + high viremia. • Acute HIV syndrome may be seen – but difficult to diagnose and often missed. Acute HIV Syndrome • • • • • • • • Fever Lymphadenopathy Pharyngitis Rash (morbilliform) Myalgia Headache N/V/D Occurs 2-4 weeks after infection and resolves in 1-4 weeks. HIV Infection • Seroconversion occurs 3-4 weeks after transmission but may take up to 6 months. • For pregnant mothers - Implications for testing - If negative in the first trimester, may want to retest in 3rd trimester if high risk. HIV Infection • Timeline Transmission of the virus ------------ 2-3 weeks. Acute HIV syndrome --------- 2-3 weeks Seroconversion/ Asymptomatic disease -------- Average 5-8 years. Symptomatic disease/AIDS HIV Infection CD4 cells destruction – average 50/year. • In some clients this may be slower – these are called long term non-progressors. •In some the progression is much faster and and they will advance to an AIDS diagnosis in 3-5 years. HIV Infection • Progression to AIDS is faster in children– usually 5 years or less. • Less HAART medication options than in the adult. • Prevention is therefore very important. Clinical Categories A B C CD4 Asymptomatic PGL or Acute HIV Symptomatic (not A or C) AIDS indicator condition >500 (>29%) A1 B1 C1 200-499 (14-28%) A2 B2 C2 < 200 (< 14%) A3 B3 C3 HAART Stands for Highly Active Anti Retroviral Therapy 1. True 2. False 91% 9% 1 2 What’s the big deal about HAART??? Can we treat our way out of the epidemic? • Theoretically, yes: – Perinatal transmission rate = 30% • Sexual transmission rate=0.5% – Pre and post-exposure prophylaxis to HIV infected mothers/fetus lowers infection to less than 1/100 • Similar effectiveness would lower sexual transmission to 0.0002 or 1/5,000, probably enough to make R<1! – The problems are practical: • Identifying all infected • Treating large numbers of patients • Treating un-infected persons for the purpose of prevention – Treat breastfeeding moms? • Currently for every 1-2 persons starting treatment, 5 new infections Adherence With poor adherence, there will be viral evolution and virologic failure. But this does not reflect how well HAART works; it reflects drug-taking behavior. With good adherence, patients do not experience spontaneous virologic failure, indicating that clinically significant viral evolution is not occurring. Robert F. Siliciano, MD, PhD Adherence • Adherence is taking the correct medication, at the correct time and in the correct way. • Missing doses of HIV medication results in a lower blood level of the medication. • The lower blood level of the medication allows greater replication of the virus. • At higher viral blood levels, there will be more viral mutations which can lead to drug resistance. • Optimal suppression is considered to occur at 95% adherence level or above. Resistance is Futile Drug Resistance • The ability of the virus to multiply in spite of the presence of the antiretroviral drug. • Drug resistance -failure- requires changing to less desirable regimens (increased pill burden and more frequent dosing). • Patients with drug resistance to 2 classes will have a greater than 50% incidence of AIDS event or death, resistance to 3 classes – an 80% greater incidence, compared to one or no class resistance Drug Resistance • Drug resistance occurs due to mutations present on the viral genetic material. • Mutations are very common in the replication process, up to 90% of new viruses have mutations that prevent them from being infective. A less fit virus! • Mutations are random and the number of mutations occurring are proportional to the viral load. • Certain mutations that occur can confer resistance to a specific medication or class of medication Drug Resistance Resistance evaluated by : Phenotype testing- the virus is grown in the presence of antiretroviral medication to determine sensitivity. Genotype testing- the viruses genetic code is tested to determine specific mutations which are known to confer resistance. DHHS Antiretroviral Therapy Guidelines: December 2009 Recommended Timing for Initiating Therapy Consider Favor: 50% of panel Optional: 50% of panel Recommend Strong: 55% of panel Moderate: 45% of panel 500 350 Strongly Recommend Source: AIDS Info (www.aidsinfo.nih.gov) Prevention of Transmission • • • • Abstinence works Condoms are protective Get tested—know your status If participating in risk behaviors, test minimally once a year—better every six months Each year in the U.S., how many people die from HIV? 1. 2. 3. 4. 5. None 5,000 10,000 50,000 >75,000 52% 30% 9% 3% 1 2 3 4 6% 5 Opportunistic Infections Bacterial, viral or protozoan infections seen in patients with CD4 counts of less than 200. This may also include some malignancies. Opportunistic Illness (OI) • Candidiasis (esophagus, trachea, lungs, bronchi). • Cervical cancer (invasive) • Cryptococcus. • Coccidioidomycosis (extrapulmonary). • Cryptosporidiosis with diarrhea for > 1 mos. Opportunistic Illness (OI) • CMV of any organ other than lymph node, spleen or eye. • Histoplasmosis (extrapulmonary). • HIV associated dementia. • HIV associated wasting syndrome (10% baseline) • Isoporosis with diarrhea > 1 month. Opportunistic Illness • • • • • Kaposi’s Sarcoma. Burkitt’s Lymphoma. Mycobacterium Avium (disseminated MAC). Pneumocystis Carinii Pneumonia. Progressive Multifocal Leukoencephalopathy (PML). Opportunistic Illness • Salmonella Septicemia (non typhoid recurrent). • Toxoplasmosis of internal organ. Questions